FERMENTA BIOTECH LIMITED (FERMENTA.BO)
INR 393.0
(-0.57%)
INR 393.0
(-0.57%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 754.2 Million INR | 10.21% |
| 2022 | 684.3 Million INR | 8.75% |
| 2021 | 629.22 Million INR | 13.5% |
| 2020 | 554.36 Million INR | -12.28% |
| 2019 | 631.97 Million INR | -6.65% |
| 2018 | 677.01 Million INR | 47.27% |
| 2017 | 459.7 Million INR | 49.85% |
| 2016 | 306.77 Million INR | 42.84% |
| 2015 | 214.77 Million INR | -63.86% |
| 2014 | 594.23 Million INR | 32.81% |
| 2013 | 447.43 Million INR | 29.51% |
| 2012 | 345.48 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 157.75 Million INR | -59.84% |
| 2023 Q3 | 276.89 Million INR | 9.62% |
| 2023 Q4 | 392.81 Million INR | 41.86% |
| 2023 FY | 643.67 Million INR | -5.94% |
| 2023 Q1 | 272.35 Million INR | -6.04% |
| 2023 Q2 | 252.58 Million INR | -7.26% |
| 2022 FY | 684.3 Million INR | 8.75% |
| 2022 Q3 | 277.04 Million INR | -15.98% |
| 2022 Q1 | 308.76 Million INR | 2.55% |
| 2022 Q4 | 289.85 Million INR | 4.63% |
| 2022 Q2 | 329.74 Million INR | 6.8% |
| 2021 Q4 | 301.08 Million INR | -5.12% |
| 2021 Q1 | 294.19 Million INR | -0.07% |
| 2021 FY | 629.22 Million INR | 13.5% |
| 2021 Q2 | 296.74 Million INR | 0.87% |
| 2021 Q3 | 317.33 Million INR | 6.94% |
| 2020 Q4 | 294.4 Million INR | -32.1% |
| 2020 Q3 | 433.56 Million INR | 3.22% |
| 2020 Q2 | 420.02 Million INR | -1.34% |
| 2020 FY | 554.36 Million INR | -12.28% |
| 2020 Q1 | 425.73 Million INR | 33.01% |
| 2019 Q2 | 428.27 Million INR | 14.33% |
| 2019 Q4 | 320.07 Million INR | -11.12% |
| 2019 Q1 | 374.57 Million INR | -7.27% |
| 2019 Q3 | 360.11 Million INR | -15.92% |
| 2019 FY | 631.97 Million INR | -6.65% |
| 2018 Q2 | 393.52 Million INR | 17.36% |
| 2018 FY | 677.01 Million INR | 47.27% |
| 2018 Q4 | 403.95 Million INR | -14.41% |
| 2018 Q3 | 471.97 Million INR | 19.94% |
| 2018 Q1 | 335.31 Million INR | -18.25% |
| 2017 Q3 | 402.58 Million INR | 28.93% |
| 2017 Q4 | 410.17 Million INR | 1.89% |
| 2017 Q2 | 312.25 Million INR | 32.75% |
| 2017 FY | 459.7 Million INR | 49.85% |
| 2017 Q1 | 235.22 Million INR | -46.18% |
| 2016 FY | 306.77 Million INR | 42.84% |
| 2016 Q1 | 210.17 Million INR | -13.77% |
| 2016 Q2 | 2.52 Million INR | -98.8% |
| 2016 Q3 | 228.83 Million INR | 8959.3% |
| 2016 Q4 | 437.05 Million INR | 90.99% |
| 2015 Q2 | 191.92 Million INR | 8.87% |
| 2015 Q4 | 243.74 Million INR | 33.2% |
| 2015 Q3 | 182.99 Million INR | -4.65% |
| 2015 FY | 214.77 Million INR | -63.86% |
| 2015 Q1 | 176.28 Million INR | 233.2% |
| 2014 Q3 | 171.25 Million INR | -13.23% |
| 2014 Q1 | 172.58 Million INR | 3111.44% |
| 2014 FY | 594.23 Million INR | 32.81% |
| 2014 Q2 | 197.37 Million INR | 14.37% |
| 2014 Q4 | 52.9 Million INR | -69.11% |
| 2013 Q2 | 138.44 Million INR | 1.29% |
| 2013 Q4 | 5.37 Million INR | -96.78% |
| 2013 Q3 | 166.92 Million INR | 20.57% |
| 2013 Q1 | 136.68 Million INR | 142.75% |
| 2013 FY | 447.43 Million INR | 29.51% |
| 2012 FY | 345.48 Million INR | 0.0% |
| 2012 Q4 | 56.3 Million INR | -53.33% |
| 2012 Q3 | 120.64 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.24 Million INR | -60723.306% |
| Biocon Limited | 40.9 Billion INR | 98.156% |
| Blue Jet Healthcare Limited | 531.85 Million INR | -41.809% |
| Concord Biotech Limited | 1.45 Billion INR | 48.331% |
| Dishman Carbogen Amcis Limited | 5.14 Billion INR | 85.348% |
| GENOMIC VALLEY BIOTECH LIMITED | 375 Thousand INR | -201022.4% |
| Lyka Labs Limited | 599.4 Million INR | -25.826% |
| Panacea Biotec Limited | 1.99 Billion INR | 62.203% |
| SAMSRITA LABS LIMITED | 1.49 Million INR | -50268.577% |
| Servoteach Industries Limited | 785.00 INR | -96077479.618% |
| SMS Lifesciences India Limited | 602.96 Million INR | -25.083% |
| Supriya Lifescience Limited | 1.08 Billion INR | 30.176% |
| Syngene International Limited | 5.99 Billion INR | 87.419% |
| TAKE Solutions Limited | 396.91 Million INR | -90.02% |
| Titan Biotech Limited | 117.05 Million INR | -544.309% |
| Transgene Biotek Limited | 5.39 Million INR | -13874.597% |
| Vanta Bioscience Limited | 38.95 Million INR | -1835.954% |